Medpace Holdings MEDP
NASDAQ MEDP
$615.11 -1.33 (-0.22%)
As of: Sep 17, 2026 · 3:59 PM EDT

Medpace Holdings (MEDP) Non-Current Deffered Revenue (2017 - 2018)

Medpace Holdings' (MEDP) quarterly Non-Current Deffered Revenue came in at $4.0 million in Q3 2018, down 81.14% on a YoY basis from $21.0 million in Q3 2017, and down 64.26% quarter-over-quarter from $11.1 million in Q2 2018.

Analysis

Medpace Holdings (MEDP) Non-Current Deffered Revenue (2017 - 2018) Analysis & Trends

Medpace Holdings (MEDP) has reported Non-Current Deffered Revenue for 2 consecutive years, with $4.0 million the latest figure, recorded in Q3 2018.

  • For the quarter ending Q3 2018, Non-Current Deffered Revenue fell 81.14% year-over-year to $4.0 million; the trailing twelve-month figure through Sep 2018 stood at $4.0 million (down 81.14% YoY), and the FY2017 full-year result was $11.5 million, changed N/A from the prior year.
  • Non-Current Deffered Revenue fell to $4.0 million in Q3 2018 per MEDP's latest filing, from $11.1 million in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $21.4 million in Q2 2017 and bottomed at $4.0 million in Q3 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn -
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn -
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn -
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn -
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn -
6 Evotec SE 574.75 Mn 148.87 Mn - 158.90 Mn
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn 76.54 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn -
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn -
10 VivoSim Labs 1.37 Mn 1.37 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2018 3.95 Mn
Jun 30, 2018 11.06 Mn
Mar 31, 2018 11.27 Mn
Dec 31, 2017 11.47 Mn
Sep 30, 2017 20.96 Mn
Jun 30, 2017 21.42 Mn